Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

UK increasingly confident COVID-19 vaccines work against Indian variant

Published 05/19/2021, 08:24 AM
Updated 05/19/2021, 01:26 PM
© Reuters. A sign directing people to a testing station, amid the outbreak of the coronavirus disease (COVID-19) in Bolton, Britain, May 16, 2021. REUTERS/Phil Noble

By Alistair Smout

LONDON (Reuters) -Britain is increasingly confident that vaccines work against the coronavirus variant first found in India, Prime Minister Boris Johnson said on Wednesday, with a leading epidemiologist saying it may be spreading less quickly than first feared.

Johnson has warned that the emergence of the B.1.617.2 variant might derail his plans to lift England's lockdown fully on June 21, but on Wednesday he said the latest data had been encouraging.

"We have increasing confidence vaccines are effective against all variants, including the Indian variant," he told parliament.

Johnson last week said the extent to which the variant could disrupt the planned exit from lockdown would depend on how much more transmissible it was.

British health minister Matt Hancock told a media conference there had been 2,967 cases of the variant, and reiterated that a decision on the next stage of easing of social restrictions would not take place until June 14.

England's deputy chief medical officer Jonathan Van-Tam said the best estimate was that the Indian variant was somewhere between a few percent and 50% more transmissible, and data should provide a clearer picture next week.

"I think most people feel it is going to be somewhere in the middle, rather than at the extremes of that band," Van-Tam told a media conference.

Neil Ferguson, an epidemiologist at Imperial College London, said there was a "glimmer of hope" from the latest data that the transmissibility of the variant might be lower than first feared.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"The magnitude of that advantage seems to have dropped a little bit with the most recent data," he told BBC radio, adding more data was needed.

He said that while it was likely vaccines would continue to protect against severe disease, the variant might lead to reduced vaccine efficacy against infection and transmission.

Ferguson said the initial rapid growth of B.1.617.2 had been among people who had travelled, were more likely to live in multi-generational households or in deprived areas, and that the ease of transmission might not be replicated in other settings.

Graham (NYSE:GHM) Medley, a professor of disease modelling at the London School of Hygiene and Tropical Medicine and a member of the government's Scientific Advisory Group for Emergencies (SAGE), said that while the variant was growing quickly in some hotspots, "we haven't yet seen it take off and grow rapidly everywhere else".

"One of the key things we'll be looking for in the coming weeks will be: how far does it spread outside of those areas," he told Reuters.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.